Eva Radetić

ORCID: 0000-0003-0315-2950
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Diseases and Immunity
  • Vitamin D Research Studies
  • Vitamin C and Antioxidants Research
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pediatric Hepatobiliary Diseases and Treatments
  • Bone health and osteoporosis research

Klinička bolnica "Sveti Duh"
2022

University of Zagreb
2019-2022

25-Hydroxyvitamin D (25-OHD) may have a prognostic value in colorectal cancer (CRC) patients. However, as 25-OHD concentration is strongly impacted by surgery, it uncertain what the most reliable time-point for assessment, pre- or post-operative. Therefore, we examined 515 CRC patients (AJCC I-III) who underwent surgery. Blood samples were collected either pre-operatively (n = 286; median 1 day before surgery) post-operatively 229; 8 days). Serum was determined liquid chromatography–tandem...

10.1080/01635581.2019.1597135 article EN Nutrition and Cancer 2019-04-04

To compare the long-term outcomes between liver transplant (LT) recipients with hepatocellular carcinoma (HCC) who were downstaged transarterial-chemoembolization (TACE) to Milan criteria (MC) and those initially meeting MC.This retrospective study enrolled 198 patients HCC: 38 160 met MC. Post-LT survival HCC recurrence-free evaluated. We assessed association of death recurrence TACE, baseline (age, sex, disease etiology, Model End-stage Liver Disease, tumor number sum maximum diameters,...

10.3325/cmj.2022.63.317 article EN cc-by-nc-nd Croatian Medical Journal 2022-08-01
Coming Soon ...